Holen Sie sich die Stockscreener-App
17.37
0.98%
-0.1251
Schlusskurs vom Vortag:
$17.50
Offen:
$17.5
24-Stunden-Volumen:
830.42K
Relative Volume:
0.54
Marktkapitalisierung:
$1.42B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$58.52M
KGV:
26.62
EPS:
0.6528
Netto-Cashflow:
$191.78M
1W Leistung:
-5.36%
1M Leistung:
-16.25%
6M Leistung:
-23.02%
1J Leistung:
-12.66%
1-Tages-Spanne:
$17.00
$17.64
1-Wochen-Bereich:
$17.00
$18.50
52-Wochen-Spanne:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
17.39 | 1.43B | 1.29B | 58.52M | 191.78M | 0.6528 |
|
UNH
Unitedhealth Group Inc
|
282.01 | 251.47B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
76.64 | 96.78B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
267.72 | 70.07B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
292.45 | 63.54B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
166.03 | 19.65B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny at Barclays Healthcare Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers Progyny (NASDAQ:PGNY) Price Target to $19.00 - MarketBeat
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Canaccord lowers Progyny stock price target on covered lives concerns By Investing.com - Investing.com Canada
Barclays PLC Purchases 696,447 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny’s Dual Use of Buybacks and ESOP Shares Raises a Key Capital Allocation Question (PGNY) - simplywall.st
Progyny at Leerink Conference: Strategic Expansion in Healthcare - Investing.com
Quantbot Technologies Reduces Stake in Progyny - National Today
Quantbot Technologies LP Reduces Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. $PGNY Shares Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
US Stocks Recap: Is Progyny Inc a good ESG investmentMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Progyny (PGNY) Receives a Buy from Truist Financial - The Globe and Mail
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Will Progyny Inc. stock deliver strong dividend growthPortfolio Value Report & Reliable Breakout Stock Forecasts - Naître et grandir
Jefferies Maintains Buy on PGNY (Progyny, Inc.) March 2026 - Meyka
Jefferies cuts Progyny stock price target on guidance miss By Investing.com - Investing.com Australia
Jefferies cuts Progyny stock price target on guidance miss - Investing.com India
Progyny, Inc. Leadership to Participate in Key Investor Conferences in March 2026 - Quiver Quantitative
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences - GlobeNewswire
Progyny leaders hit March healthcare stages on fertility tech - Stock Titan
BTIG Research Lowers Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
BTIG lowers Progyny stock price target to $30 on client loss impact - Investing.com Nigeria
BTIG lowers Progyny stock price target to $30 on client loss impact By Investing.com - Investing.com South Africa
Is Progyny (PGNY) Using Buybacks and Employee Stock Plans to Recast Its Growth Story? - Yahoo Finance
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Selling: Progyny (NASDAQ:PGNY) EVP Sells 4,657 Shares of Stock - MarketBeat
Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 2,199 Shares - MarketBeat
[Form 4] Progyny, Inc. Insider Trading Activity - Stock Titan
Progyny (PGNY) EVP Allison Swartz receives equity grants and sells shares - Stock Titan
Progyny (NASDAQ: PGNY) CEO receives RSUs, options and withholds shares for taxes - Stock Titan
Allison C. Swartz sells shares; PGNY (NASDAQ: PGNY) Form 144 notice - Stock Titan
Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha
Is Progyny (PGNY) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Progyny, Inc. Hits Day Low of $16.75 Amid Price Pressure - Markets Mojo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Alkermes (ALKS) and Progyny (PGNY) - The Globe and Mail
Allison Swartz to sell 4,657 PGNY shares (NASDAQ: PGNY) in vesting sale - Stock Titan
Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector - DirectorsTalk Interviews
INVO Fertility's Wisconsin Clinic Joins Progyny Network - Bitget
INVO Fertility (IVF) Clinic Joins Progyny Network, Expanding Pat - GuruFocus
INVO Fertility’s Wisconsin Clinic Joins Progyny Network - marketscreener.com
Progyny deal brings INVO fertility care in-network in Wisconsin - Stock Titan
Progyny (PGNY): Truist Securities Lowers Price Target to $28 | P - GuruFocus
JPMorgan Chase & Co. Trims Position in Progyny, Inc. $PGNY - MarketBeat
Intech Investment Management Boosts Progyny Stake by 336% - National Today
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
PGNY (NASDAQ: PGNY) insider sale notice lists 2,199 common shares - Stock Titan
Does Progyny's (PGNY) Buyback and ESOP Shelf Quietly Reframe Its Growth Story? - simplywall.st
PGNY Sees Revised Price Target Despite Maintained Overweight Rat - GuruFocus
Progyny (NASDAQ:PGNY) Given New $28.00 Price Target at KeyCorp - MarketBeat
KeyBanc lowers Progyny stock price target on conservative estimates By Investing.com - Investing.com Canada
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):